This set of Homerun Slides put together by Diabetes In Control staff is specifically geared towards the cardiovascular benefits of incretins. Link to download (.ppt format): GLP-1 Agonists and Cardiovascular Health, Part 1 of 2 Other sets in this series: GLP-1 Agonists and Cardiovascular Health, Part 2 of 2 See more GLP-1 Agonist …
Read More »Global Dimensions of Sugary Beverages in Programmatic and Policy Solutions, Part 2 of 2
In this week’s Homerun Slides, Dr. Barry Popkin continues his exploration of the impact of sugary beverages on health worldwide, examining data on the relationship between recent historical weight gains and the increase in consumption of these beverages. In addition, Dr. Popkin presents us with some current policy changes …
Read More »Global Dimensions of Sugary Beverages in Programmatic and Policy Solutions, Part 1 of 2
In this week’s Homerun Slides series, we have some great information for you on the evolution of sugary beverages in the modern era and how those changes are affecting our health world-wide from Dr. Barry Popkin…
Read More »Use of the Estimated Average Glucose (eAG) in Patient Care, Part 2 of 2
This week, we bring you part 2 of Homerun Slides short series on Estimated Average Glucose, covering topics including What Can Clinicians and Educators Do? and What Can Clinical Chemists Do? to help patients understand eAG…
Read More »Use of the Estimated Average Glucose (eAG) in Patient Care, Part 1 of 2
In this week’s Homerun Slides, we examine the use of eAG which is not always just confusing to patients.
Read More »Diabetes: Exploring the Risks and Benefits of Emerging Type 2 Therapies, Part 2 of 2
Part 2 of our short series on some of the newer diabetes therapies inludes a glance at some of what is in the pipeline….
Read More »Diabetes: Exploring the Risks and Benefits of Emerging Type 2 Therapies, Part 1 of 2
Part 1 of this two-part series covers some of the newest therapies for type 2 diabetes including GLP-1 agonists and DPP-4 inhibitors. We also take a look at some of the even newer therapies on the horizon such as SGLT2 inhibitors, ultra long-acting insulin (degludec) and interleukin-1 blocker, diacerein.
Read More »Complementary Alternative Medicine Treatments in Diabetes
This week’s selection of Homerun Slides cover some of the alternative medicines, (such as cinnamon, aloe, ginseng, stevia and tea) that your patients may be asking you about along with some helpful sources to find out more about these Complementary Alternative Medicines (CAMs)….
Read More »ADA-EASD Position Statement: Management of Hyperglycemia in T2DM, Part 4 of 4
This week’s set of Homerun Slides wraps up our series on the new ADA-EASD Position Statement: Management of Hyperglycemia in T2DM. "Other Considerations" topics covered include Renal Disease, Liver Dysfunction and Hypoglycemia, and Guidelines for Glycemia, BP, & Lipid Control are also provided….
Read More »ADA-EASD Position Statement: Management of Hyperglycemia in T2DM, Part 3 of 4
In this week’s Homerun Slides, topics covered include Other Considerations when dealing with Hyperglycemia in T2DM such as Age, Weight, Sex/Racial/Ethnic/Genetic differences, and Co-morbidities (Coronary artery disease, Heart Failure, Chronic kidney disease, Liver dysfunction, and Hypoglycemia)….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.